Trexquant Investment »

Kalaris Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $121k 30k 4.07

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Alyeska Investment Group
Siren
Vanguard Capital Management
Ikarian Capital
UBS Group
Renaissance Technologies
Marshall Wace
Geode Capital Management
ADAR1 Capital Management
Woodline Partners
Whi Trust
Raymond James Financial
Citadel Advisors

View all funds holding Kalaris Therapeutics